Literature DB >> 32080837

Minimal residual disease analysis in childhood mature B-cell leukaemia/lymphoma treated with AIEOP LNH-97 protocol with/without anti-CD20 administration.

Lara Mussolin1,2, Federica Lovisa1,2, Ilaria Gallingani1, Elena Cavallaro1, Elisa Carraro1, Carlotta C Damanti1, Luciana Vinti3, Alessandra Sala4, Concetta Micalizzi5, Nicola Santoro6, Matilde Piglione7, Monica Cellini8, Salvatore Buffardi9, Barbara Buldini1, Emanuele S G D'Amore10, Alessandra Biffi1,2,11, Marta Pillon1.   

Abstract

Entities:  

Keywords:  AIEOP LNH-97; B-cell acute leukaemia; Burkitt; anti-CD20; minimal residual disease; paediatric

Mesh：

Substances：

Year:  2020        PMID： 32080837     DOI： 10.1111/bjh.16531

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

Review 1.  Primary breast lymphoma of childhood: a case report and review of literature.

Authors:  Giulia A Restivo; Marta Pillon; Lara Mussolin; Clara Mosa; Angela Guarina; Angela Trizzino; Salvatore Ialuna; Elisa Carraro; Emanuele S G D'Amore; Giovanna Russo; Caterina Elia; Maurizio Mascarin; Adriana Zangara; Paolo D'Angelo; Piero Farruggia
Journal:  BMC Pediatr       Date:  2021-11-30       Impact factor: 2.125

2.  Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia.

Authors:  Paula Möker; Udo Zur Stadt; Martin Zimmermann; Malik Alawi; Stephanie Mueller; Jasmin Finger; Fabian Knörr; Amambay Riquelme; Ilske Oschlies; Wolfram Klapper; Jutta Bradtke; Birgit Burkhardt; Wilhelm Woessmann; Christine Damm-Welk
Journal:  Leukemia       Date:  2022-07-05       Impact factor: 12.883

3.  The Diagnostic Pitfalls of Mucormycosis.

Authors:  Margherita Mauro; Giuliana Lo Cascio; Rita Balter; Ada Zaccaron; Elisa Bonetti; Virginia Vitale; Matteo Chinello; Massimiliano De Bortoli; Paolo Brazzarola; Costanza Bruno; Simone Cesaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.